Hospital rules-based system: The next generation of medical informatics for patient safety

American Journal of Health-System Pharmacy

Volumn 62, Issue 5, 2005, Pages 499-505

  Wilson, John W ^a   Oyen, Lance J ^a   Ou, Narith N ^a   McMahon, M Molly ^a   Thompson, Rodney L ^a   Manahan, Janice M ^a   Graner, Kevin K ^a   Lovely, Jenna K ^a   Estes, Lynn L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Communication; Computers; Documentation; Economics; Errors, medication; Hospitals; Internet; Patient care; Pharmacy, institutional, hospital; Rational therapy; Toxicity; Workload; World Wide Web

Indexed keywords

ARTICLE; COST CONTROL; DOCUMENTATION; HOSPITAL PHARMACY; HOSPITAL PLANNING; INFECTION CONTROL; MEDICAL INFORMATICS; MONITORING; NURSING; NUTRITIONAL SUPPORT; PATIENT CARE; PRIORITY JOURNAL; SAFETY; WORKLOAD;

EID: 14744297818     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/62.5.499     Document Type: Article

References (27)

1. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995; 274:29-34.
2. Leape LL, Bates DW, Cullen DJ et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995; 274:35-43.
3. Agency for Healthcare Research and Quality. Medical errors: the scope of the problem. www.ahrq.gov/qual/errback.htm (accessed 2004 Dec 12).
4. Bates DW, Gawande AA. Improving safety with information technology. N Engl J Med. 2003; 348:2526-34.
5. Murray MD, Loos B, Tu W et al. Work patterns of ambulatory care pharmacists with access to electronic guideline-based treatment suggestions. Am J Health-Syst Pharm. 1999; 56:225-32.
6. Castle M, Wilfert CM, Cate TR et al Antibiotic use at Duke University Medical Center. JAMA. 1977; 237:2819-22.
7. Maki DG, Schuna AA. A study of antimicrobial misuse in a university hospital. Am J Med Sci. 1978; 275:271-82.
8. Achong MR, Wood J, Theal HK et al. Changes in hospital antibiotic therapy after a quality-of-use study. Lancet. 1977; 2:1118-22.
9. Roberts AW, Visconti JA. The rational and irrational use of systemic antimicrobial drugs. Am J Hosp Pharm. 1972; 29:828-34.
10. Lodise TP, McKinnon PS, Swiderski L et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003; 36:1418-23.
11. Ibrahim EH, Sherman G, Ward S et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000; 118:146-55.
12. Leibovici L, Shraga I, Drucker M et al. The benefit of appropriate empirical antibiotic treatment in patients with blood-stream infection. J Intern Med. 1998; 244:379-86.
13. Goldmann DA, Weinstein RA, Wenzel RP et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996; 275:234-40.
14. Baughman RP. Antibiotic resistance in the intensive care unit. Curr Opin Crit Care. 2002; 8:430-4.
15. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med. 2001; 134:298-314.
16. Kollef MH, Ward S, Sherman G et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med. 2000; 28:3456-64.
17. Infectious Diseases Society of America. Bad bugs, no drugs. Defining the antimicrobial availability problem. www.idsociety.org/Template.cfm? Section=Home&CONTENTID=7455& TEMPLATE=/ContentManagement/ContentDisplay. cfm (accessed 2004 Dec 20).
18. Hirsh J, Warkentin TE, Shaughnessy SG et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001; 119(1, suppl): 64S-94S.
19. Braunwald E, Antman EM, Beasley JW et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol. 2002; 40:1366-74.
20. Cohen MR, Kilo C. High-alert medications: safeguarding against errors. In: Cohen MR, ed. Medication errors. Washington, DC: American Pharmaceutical Association; 1999:5.24-5.26.
21. Kuperman GJ, Gibson RF. Computer physician order entry: benefits, costs, and issues. Ann Intern Med. 2003; 139:31-9.
22. Bates DW, Miller EB, Cullen DJ et al. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med. 1999; 159:2553-60.
23. Gandhi TK, Weingart SN, Borus J et al. Adverse drug events in ambulatory care. N Engl J Med. 2003; 348:1556-64.
24. Volpp KG, Grande D. Residents' suggestions for reducing errors in teaching hospitals. N Engl J Med. 2003; 348:851-5.
25. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med. 2003; 163:1409-16.
26. Teich JM, Merchia PK, Schmiz JL et al. Effects of computerized physician order entry on prescribing practices. Arch Intern Med. 2000; 160:2741-7.
27. Institute for Safe Medication Practices. Medication safety alerts: new data monitoring technology offers real-time reporting of adverse events. www.ismp.org/MSAarticles/newdata.htm (accessed 2004 Dec 20).